{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT02279498: Phase 3 Interventional Completed Exocrine Pancreatic Insufficiency
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT01081691: Phase 1 Interventional Completed Healthy
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00003478: Phase 1/Phase 2 Interventional Completed Brain and Central Nervous System Tumors
(1997)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:dezamizumab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00001564: Phase 2 Interventional Completed Ewing's Sarcoma
(1996)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02279498: Phase 3 Interventional Completed Exocrine Pancreatic Insufficiency
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:pegapamodutide [INN]
Source URL:
Class:
PROTEIN